Lu Han

No. 9 Beijing Road
Guiyang, 550004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

M2 macrophage-derived apoptotic vesicles alleviate liver fibrosis via miR-1224-5p-mediated inhibition of the SP1/TGF-β pathway in hepatic stellate cells.

M2 macrophage-derived apoptotic vesicles alleviate liver fibrosis via miR-1224-5p-mediated inhibition of the SP1/TGF-β pathway in hepatic stellate cells.

Journal: Journal of nanobiotechnology

Published: October 29, 2025

AKR1C3 promotes aerobic glycolysis in hepatic stellate cells via the AKT/mTOR pathway to induce liver fibrosis.

AKR1C3 promotes aerobic glycolysis in hepatic stellate cells via the AKT/mTOR pathway to induce liver fibrosis.

Journal: Cellular signalling

Published: October 05, 2025

Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma.

Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma.

Journal: NPJ precision oncology

Published: September 15, 2025

FAK-TRIM25 promotes HSC activation and glycolysis by inhibiting c-Myc ubiquitination via FBXW7.

FAK-TRIM25 promotes HSC activation and glycolysis by inhibiting c-Myc ubiquitination via FBXW7.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: September 02, 2025

Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells.

Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells.

Journal: Human mutation

Published: August 12, 2025

Glycochenodeoxycholic acid induces the release of IL-1beta from L02 cells via the NLRP3/caspase-1/GSDMD pathway to activate LX2 cells.

Glycochenodeoxycholic acid induces the release of IL-1beta from L02 cells via the NLRP3/caspase-1/GSDMD pathway to activate LX2 cells.

Journal: Journal of inflammation research

Published: April 02, 2025

Correction: Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.

Correction: Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.

Journal: Hepatology international

Published: March 27, 2025

FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation.

FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation.

Journal: World journal of gastroenterology

Published: March 21, 2025

CLDN9 and hsa-miR-4496 as non-invasive biomarkers for gastric cancer detection.

CLDN9 and hsa-miR-4496 as non-invasive biomarkers for gastric cancer detection.

Journal: Discover oncology

Published: November 04, 2024

Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis.

Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis.

Journal: Scientific reports

Published: September 11, 2024

Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway.

Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 03, 2024

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing.

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing.

Journal: Frontiers in immunology

Published: April 17, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026